Glial bundle formation in spinal roots following experimental neuronopathy

Cell Transplantation to Restore Lost Auditory Nerve Function is a Realistic Clinical Opportunity

Hearing is one of our most important means of communication. Disabling hearing loss (DHL) is a long-standing, unmet problem in medicine, and in many elderly people, it leads to social isolation, depression, and even dementia. Traditionally, major efforts to cure DHL have focused on hair cells (HCs). However, the auditory nerve is also important because it transmits electrical signals generated by HCs to the brainstem. Its function is critical for the success of cochlear implants as well as for future therapies for HC regeneration. Over the past two decades, cell transplantation has emerged as a promising therapeutic option for restoring lost auditory nerve function, and two independent studies on animal models show that cell transplantation can lead to functional recovery. In this article, we consider the approaches most likely to achieve success in the clinic. We conclude that the structure and biochemical integrity of the auditory nerve is critical and that it is important to preserve the remaining neural scaffold, and in particular the glial scar, for the functional integration of donor cells. To exploit the natural, autologous cell scaffold and to minimize the deleterious effects of surgery, donor cells can be placed relatively easily on the surface of the nerve endoscopically. In this context, the selection of donor cells is a critical issue. Nevertheless, there is now a very realistic possibility for clinical application of cell transplantation for several different types of hearing loss.

Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Spinal muscular atrophy (SMA) is a genetic neurological disease that causes infant mortality; no effective therapies are currently available. SMA is due to homozygous mutations and/or deletions in the survival motor neuron 1 gene and subsequent reduction of the SMN protein, leading to the death of motor neurons. However, there is increasing evidence that in addition to motor neurons, other cell types are contributing to SMA pathology. In this review, we will discuss the involvement of non-motor neuronal cells, located both inside and outside the central nervous system, in disease onset and progression. Even if SMN restoration in motor neurons is needed, it has been shown that optimal phenotypic amelioration in animal models of SMA requires a more widespread SMN correction. It has been demonstrated that non-motor neuronal cells are also involved in disease pathogenesis and could have important therapeutic implications. For these reasons it will be crucial to take this evidence into account for the clinical translation of the novel therapeutic approaches.

Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning

Toxic lectins, plant proteins that inactivate ribosomes, irreversibly inhibit protein synthesis with high efficiency. After intraneural (subepineurial) microinjection, these agents are taken up by axons and are retrogradely transported to the perikarya, where they result in cell death. These 'suicide transport' toxins can produce pathway-specific lesions that are useful in several types of experiment, including cellular localization of neurotransmitter receptors. The toxins can be coupled to monoclonal antibodies to produce immunotoxins: reagents that can make highly selective lesions of specific types of neurons. Central or peripheral neurons that express the low-affinity NGF receptor are selectively destroyed by the immunotoxin 192 IgG-saporin. Development of other anti-neuronal immunotoxins should provide a variety of powerful selective lesioning tools.

Peripheral nerve involvement in Werdnig-Hoffmann disease

The number of large myelinated axons was markedly decreased in almost all the intramuscular nerve bundles included in 32 muscle biopsies from patients with Werdnig-Hoffmann disease compared to that in normals. The morphometric analysis of peripheral nerves in 5 epon-embedded sections also showed a selective loss of larger myelinated fibers. The ultrastructural findings of the nerves were similar to those seen in Wallerian degeneration including axonal degeneration, myelin breakdown with phagocytosis, Schwann cell proliferation forming Schwann cell columns, axonal sprouting and probable remyelination. The earlier and more striking peripheral nerve involvement than that previously believed was not different from that seen in amyotrophic lateral sclerosis (ALS). The earlier damage to the peripheral nerves probably resulted from a degeneration of the anterior horn cells or anterior spinal roots as in ALS rather than from a dying-back process.